Obesity at 50 to 65 in India

For most of adult life, oestrogen nudges the body to store fat in "gynoid" depots, the hips and thighs, and helps keep deep abdominal fat relatively low. As oestrogen falls during the menopause transition, that pattern reverses: more energy is routed into visceral adipose tissue, the metabolically active fat packed around the liver, pancreas, and intestines. This is a hormonal shift in where fat sits, not a failure of diet or discipline.

The change is measurable and steep. In the SWAN Heart study of 362 US women (mean baseline age 51.1 years), CT-measured visceral fat was stable until about two years before the final menstrual period, then rose by roughly 8.2% per year up to the final period and 5.8% per year afterwards, even after adjusting for age, BMI, and lifestyle. A 20% higher visceral fat volume was also linked to about 2% greater thickness of the internal carotid artery wall, a marker that predicts stroke risk.

Indian women may meet this transition earlier than Western reference populations. A PAN-India survey by the Indian Menopause Society reported an average age at natural menopause of 46.2 years, against around 51 in Western cohorts. That figure comes from a clinic- and community-based sample, not a nationally representative survey such as NFHS or ICMR, so it is suggestive rather than settled. Taken at face value, it implies many Indian women complete the high-risk visceral-fat shift in their mid-to-late 40s, arriving at 50 with several years of accelerated abdominal fat gain already behind them.

Fat gain is only one side of what happens after 50. The other is muscle, and Indian bodies start from a lower base. In the Sarco-CUBES study of 804 apparently healthy Indian adults, peak grip strength, muscle-mass index, and walking speed were reached in the third to fourth decade of life, with decline setting in from the 40s onwards. By 50 to 65, that downward slope is well established.

Because Indian frames are generally smaller, the thresholds that define "low" muscle are lower here than in Western guidance. Sarco-CUBES set low grip strength at below 27.5 kg for men and 18.0 kg for women, and low muscle-mass index at 6.11 kg/m² for men and 4.61 kg/m² for women. On those Indian-specific cut-offs, probable sarcopenia was present in 14.6% of adults, with prevalence rising with age. Using Western reference ranges would misclassify many Indians in both directions.

The combination that matters most is sarcopenic obesity: high visceral fat alongside low muscle. Weight can hold steady for years while body composition worsens underneath, which is why muscle function needs direct measurement.

By 50, a large share of Indian adults are carrying at least one metabolic condition. The ICMR-INDIAB survey, a national door-to-door study, found weighted diabetes prevalence of 10.4%, with urban rates running higher than rural in every region. Abdominal obesity (waist 90 cm or more in men, 80 cm or more in women) reached up to 36.1%, with urban women the most centrally obese group.

The cardiovascular timeline is compressed for South Asians. In the INTERHEART study of 15,152 heart-attack cases and 14,820 controls across 52 countries, the mean age at first heart attack was 53.0 years in South Asian countries versus 58.8 years elsewhere. After adjusting for the nine major risk factors, the odds were similar across groups, pointing to the same risks arriving earlier and heavier rather than any separate cause.

Standard risk calculators can undersell this. When the Framingham equation was recalibrated to the urban Indian CARRS cohort of 11,407 adults, the original model classified 12.1% of men and 3.1% of women as high-risk (over 30% ten-year risk), while the recalibrated version put those figures at 20.6% of men and 16.1% of women, a near five-fold jump for women.

You may have read that South Asians develop diabetes earlier. The careful version is narrower than the headline. In a large UK study (CPRD, 179,886 people), South Asians were diagnosed with type 2 diabetes about 9.8 years earlier than white Europeans in the same health service, and at a lower BMI. It is a finding about age at clinical diagnosis in a migrant cohort, not about when insulin resistance begins, which was never measured. For a reader at 50 to 65, the point is that most people affected are already past that window, so the task now is control and complication-screening, not waiting for a first diagnosis.

Because weight and BMI miss so much at this age, a useful review tracks four systems directly: body composition, glucose regulation, cardiovascular risk, and muscle function. The following measurements reflect Indian and WHO-aligned guidance:

• Waist and waist-to-hip ratio: Measure at every visit. Abdominal obesity is defined as a waist circumference of 90 cm or more in men and 80 cm or more in women. It predicts risk better than BMI in Indians and helps identify central fat even at a normal weight.
• BMI using Indian cut-offs: Overweight begins at a BMI of 23, and obesity at 25 kg/m². Read BMI alongside waist measurements, as Western cut-offs can underestimate risk in South Asian populations.
• Fasting glucose and HbA1c: Check at least yearly, or every 3 to 6 months for people with diabetes. This helps identify dysglycaemia, which is common and often remains uncontrolled even after diagnosis.
• Fasting lipids and blood pressure: Check lipids at baseline and periodically thereafter, and blood pressure at every contact. South Asian lipid profiles are associated with earlier cardiovascular events.
• Grip strength, gait speed and SARC-F: Measure grip strength using a dynamometer against Indian cut-offs and assess walking speed over 4 metres. These tests help detect sarcopenia and sarcopenic obesity that body weight alone may conceal.
• Cardiovascular risk score: Use an India-recalibrated or ethnicity-adjusted model. Generic Framingham and WHO risk charts may underestimate cardiovascular risk, particularly in Indian women.

Where available, DXA or a validated bioimpedance scan adds a direct assessment of lean mass and visceral fat area. This is particularly useful for anyone with unexplained frailty or a "normal weight, big waist" pattern.

Reducing visceral fat is worth doing, and it responds to effort: pooled data show that combining aerobic exercise with a moderate calorie deficit can shrink CT-measured visceral fat by around 30 cm². The trap at 50 to 65 is losing muscle alongside the fat. Because Indians start with lower muscle reserves, aggressive calorie restriction without strength work risks tipping someone toward sarcopenia while the scale reports "progress."

The evidence-aligned principles are:

1. Keep resistance training central: Two to three sessions a week targeting the major muscle groups, alongside aerobic activity, helps hold or build strength while fat comes down.
2. Eat enough protein, spread across meals: Geriatric-nutrition guidance suggests roughly 1.0 to 1.2 g/kg/day in healthy older adults, rising toward 1.5 g/kg/day where sarcopenia is present, with caution in kidney disease. These thresholds are not derived from Indian trials, so treat them as a starting point to individualise with a clinician.
3. Track function, not just weight: If grip strength, walking speed, or the ability to climb stairs and rise from a chair falls during a weight-loss effort, that signals over-restriction or too little strength work, and a reason to adjust the plan.

The figures here are drawn from published primary research and national surveys: SWAN Heart for menopause and visceral fat, the Indian Menopause Society survey for age at menopause, Sarco-CUBES for Indian muscle cut-offs, ICMR-INDIAB for national diabetes and obesity prevalence, INTERHEART for cardiovascular timing, and CARRS-based recalibration for risk-score accuracy. Several gaps are worth flagging: there is no nationally weighted median age at menopause for India, no clean 50 to 65-specific national prevalence table, and no India-specific trial of muscle-preserving weight loss in this age group.

A metabolic and body-composition picture, not another round of the scale.

If you are 50 to 65, or helping a parent who is older, a body-composition and metabolic assessment with Voy's clinical team can measure waist, glucose, lipids, and muscle function together, read against Indian cut-offs, so decisions are based on what is actually changing inside your body rather than what the scale says.